» Authors » Philip D Harvey

Philip D Harvey

Explore the profile of Philip D Harvey including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 524
Citations 13299
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Badal V, Campbell L, Depp C, Parrish E, Ackerman R, Moore R, et al.
Int Psychogeriatr . 2025 Mar; 37(2):100007. PMID: 40086909
Objectives: Subjective cognitive complaints (SCC) are common and clinically relevant in mild cognitive impairment (MCI) but are intertwined with mood states. Using Ecological Momentary Assessment (EMA) of SCC and network...
2.
Parrish E, Kuehn K, Pinkham A, Moore R, Harvey P, Granholm E, et al.
Schizophr Bull . 2025 Mar; PMID: 40084583
Background And Hypothesis: People with serious mental illness (SMI) have an increased risk of suicide ideation (SI) and suicide behavior (SB). Longitudinal studies on factors contributing to SI/SB in SMI...
3.
Guzman A, Harvey P
Curr Opin Psychiatry . 2025 Feb; PMID: 40009748
Purpose Of Review: Cognitive impairment in schizophrenia (SCZ) is very common and functionally relevant, being a consistent predictor of the ability to perform critical functional skills and real-world activities, such...
4.
Horan W, Kalali A, Brannan S, Drevets W, Leoni M, Mahableshwarkar A, et al.
Schizophr Bull . 2025 Feb; 51(2):262-273. PMID: 39982834
Cognitive impairment is a core feature and leading cause of functional disability in schizophrenia and other neuropsychiatric disorders. The Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) initiative...
5.
Berretta S, Abaya N, Parrish E, McBride L, Moore R, Ackerman R, et al.
NPP Digit Psychiatry Neurosci . 2025 Feb; 3(1):5. PMID: 39959603
Poor introspective accuracy (IA), defined as inaccurate judgments of one's abilities and performance, is a strong and independent predictor of functional impairment in people with psychotic disorders. However, there are...
6.
Harvey P, Kaul I, Chataverdi S, Patel T, Claxton A, Sauder C, et al.
Schizophr Res . 2025 Jan; 276:117-126. PMID: 39889526
Background: Experiential negative symptoms (NS) are determinants of disability in schizophrenia (SCZ). Xanomeline/Trospium Chloride (X/T), an M1/M4 muscarinic receptor agonist, is an approved monotherapy for treatment of schizophrenia, including NS....
7.
Horan W, Kalali A, Brannan S, Drevets W, Mahableshwarkar A, Rao S, et al.
Schizophr Bull . 2025 Jan; 51(2):287-289. PMID: 39862390
No abstract available.
8.
9.
Harvey P, McDonald S, Fu E, Reuteman-Fowler C
Schizophr Res Cogn . 2025 Jan; 40:100340. PMID: 39759424
Clinical Trial Registration: ClinicalTrials.gov identifier: NCT03859973.
10.
Rose B, Harvey P
CNS Spectr . 2024 Dec; :1-21. PMID: 39721947
No abstract available.